Misselwitz, Frank,Kubitza, Dagmar,Park, Son-Mi,Wehling, Klaus
申请号：
NO20074356
公开号：
NO344278B1
申请日:
2007.08.27
申请国别(地区):
NO
年份:
2019
代理人:
摘要：
The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
